The Research and Development team at Elicio Therapeutics is focused on pioneering innovative therapies that harness the immune system to combat cancer. Composed of experienced scientists and research associates, the team conducts cutting-edge research, develops therapeutic candidates, and oversees preclinical and clinical trials to ensure the efficacy and safety of new cancer treatments. Their collaborative efforts aim to advance the company’s mission of enhancing patient outcomes through transformative immune re-engineering strategies.
View all